ºÚÁϳԹÏÍø

Cleveland Clinic's newly established Center for Immunotherapy & Precision Immuno-Oncology (CITI) has launched its Immunomonitoring Laboratory (IML), which will help researchers and clinicians to analyze the nature and state of immune responses of cancer patients. The IML is an institutional core and...

When Case Comprehensive Cancer Center (Case CCC) Director Stan Gerson, MD agreed to take part in an exploratory trip to Israel this past March, he could not imagine the worldwide pandemic that would descend and shake up every aspect of the trip. While conferences were canceled, meetings were resched...

The Case Comprehensive Cancer Center extends congratulations to Jill Barnholtz-Sloan, PhD, Mahmoud A. Ghannoum, PhD and Stanley Huang, PhD as they were each identified by Clarivate as some of the world's most influential researchers, most frequently cited by their peers over the last decade. In 202...

The Cancer Center will soon offer investigators isotope tracing capability through the new Cancer Metabolism Shared Resource (SR) in development. Isotope tracing analysis allows investigators to monitor pathway activities, which cannot be attained by measuring the metabolites' cellular concentration...

The Cancer Center will soon offer investigators isotope tracing capability through the new Cancer Metabolism Shared Resource (SR) in development. Isotope tracing analysis allows investigators to monitor pathway activities, which cannot be attained by measuring the metabolites' cellular concentration...

A team of Case Comprehensive Cancer Center (Case CCC) researchers were recently awarded $150,000 by the National Cancer Institute (NCI), as a supplement to the Cancer Center Support Grant, to survey cancer patients and oncology healthcare providers about the use of cannabis products during treatment...

Researchers with ºÚÁϳԹÏÍø School of Medicine and University Hospitals Cleveland Medical Center (UHCMC) have secured $5 million in funding from the National Institutes of Health (NIH)/National Cancer Institute (NCI) to establish an HIV-associated Malignancy Research Center (HAM...

David Schwartz Photography Interim President Scott Cowen and Provost Ben Vinson III announced today that Interim Dean Stan Gerson, MD has agreed to extend his term for another year, to June 30, 2022. “We knew Stan’s deep familiarity with the medical school and its hospital partners would...

John Mulvihill, MS, longtime technical manager of the Radiation Resources Facility, announced his retirement last month. John is a skilled physicist who managed the facility for over 30 years, during which time he demonstrated complete dedication to making it work for all users. Past facility direct...

The second annual Artificial Intelligence in Oncology Symposium, held virtually Monday, Oct. 19, through Tuesday, Oct. 20, is right around the corner. The virtual conference has a diverse lineup of speakers and panelists who will engage in discussions on how AI and machine learning are being used as...